BioCentury
ARTICLE | Clinical News

Dynamis preclinical data

April 9, 2001 7:00 AM UTC

Dynamis said that in diabetic rats, DYN 12 reduced urine and plasma levels of 3-deoxyglucosone (3DG), a protein cross-linker that is produced by the Amadorase enzyme. The company said that 3DG is invo...